Comparative Preclinical Evaluation of the Safety, Antifungal Activity, and Pharmacokinetics of Sertaconazole Products for External Use

• Egile Nagusiak: V. M. Kosman (Egilea), M. V. Karlina (Egilea), V. A. Vavilova (Egilea), K. E. Borovkova (Egilea), K. L. Kryshen (Egilea), N. V. Marchenko (Egilea), S. A. Kopatko (Egilea), I. V. Sychkova (Egilea), D. R. Kargopoltseva (Egilea), M. N. Makarova (Egilea), V. G. Makarov (Egilea)
• Formatua: Liburua
• Argitaratua: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2024-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

SCIENTIFIC RELEVANCE. The high prevalence of fungal skin infections motivates expanding the range of sertaconazole products for external use.AIM. The study was a preclinical comparison of the safety, antifungal activity, and pharmacokinetics of Sertaverin® 2% medicated shampoo (VERTEX JSC, Russia) w...